Form 4: Liquidia CBO Sells Shares for Tax Obligations

Liquidia Corp's Chief Business Officer, Jason Adair, executed a planned sale of 13,548 common shares to cover tax liabilities from equity award vesting.

Summary

• Jason Adair, Chief Business Officer of Liquidia Corp (LQDA), reported transactions involving the acquisition and disposition of common stock.
• On January 9, 2026, Adair acquired a total of 21,854 shares of common stock through the vesting of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs). This included 3,906 RSUs, 2,474 PSUs, and 15,474 PSUs.
• The RSUs and PSUs converted into common stock on a one-for-one basis.
• On January 12, 2026, Adair sold 13,548 shares of Liquidia common stock at a price of $37.43 per share.
• The sale was conducted pursuant to a Rule 10b5-1 plan adopted on December 15, 2023, and was specifically to cover taxes associated with the settlement of vested RSUs and PSUs.
• Following these transactions, Adair's direct beneficial ownership of Liquidia common stock stands at 184,174 shares.
• His beneficial ownership includes 10,937 unvested RSUs from a July 6, 2023 grant, 19,794 unvested RSUs from a January 11, 2024 grant, 46,421 unvested RSUs from a January 11, 2025 grant, and 11,586 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation and tax obligations, which are neutral in sentiment as they do not reflect discretionary buying or selling based on new company performance information.

Positives

• The vesting of 21,854 RSUs and PSUs indicates the achievement of time-based vesting schedules for equity compensation granted to the Chief Business Officer.
• The existence of a Rule 10b5-1 plan demonstrates pre-planned transactions, reducing concerns about opportunistic insider trading.

Negatives

• The sale of 13,548 shares, even for tax purposes, results in a reduction of the Chief Business Officer's direct equity stake in the company.

Future Outlook

The filing details future vesting schedules for outstanding equity awards, indicating continued time-based vesting for RSUs and PSUs granted on July 6, 2023, January 11, 2024, and January 11, 2025. Specifically, the remaining PSUs from the January 11, 2025 grant are expected to vest ratably on a quarterly basis over three years after January 11, 2026.

Management Comments

• The shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2023, January 11, 2024, and January 11, 2025.

Industry Context

This Form 4 filing represents a routine insider transaction related to executive compensation. Such transactions, particularly those involving sales to cover tax obligations upon equity award vesting, are common across all industries for publicly traded companies and do not typically reflect a change in management's outlook on the company's prospects. The use of a Rule 10b5-1 plan is a standard practice for insiders to pre-arrange stock transactions to avoid accusations of trading on material non-public information.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) as a form of executive compensation is a standard practice in the biotechnology and pharmaceutical industries, aligning executive incentives with long-term company performance and shareholder value.
• The adoption of a Rule 10b5-1 trading plan by an executive, such as Jason Adair, is a widely accepted corporate governance practice, consistent with industry benchmarks for managing insider stock transactions transparently and mitigating potential insider trading concerns.
• Sales of shares to cover tax liabilities upon the vesting of equity awards are a routine and expected event for executives across all sectors, including biotech, and do not typically signal a negative outlook on the company, unlike discretionary sales.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even for tax purposes, slightly reduces insider ownership, but the pre-planned nature via a 10b5-1 plan mitigates negative interpretations.
• Employees: The vesting of equity awards demonstrates the company's commitment to executive compensation plans, which can positively influence employee morale and retention.

Next Steps

• Continued vesting of 10,937 unvested RSUs from the July 6, 2023 grant.
• Continued vesting of 19,794 unvested RSUs from the January 11, 2024 grant.
• Continued vesting of 46,421 unvested RSUs from the January 11, 2025 grant, with remaining PSUs vesting ratably on a quarterly basis over three years thereafter.

Key Dates

Keywords

Liquidia Corp, LQDA, Form 4, Insider Transaction, Stock Sale, RSU Vesting, PSU Vesting, Executive Compensation, Jason Adair, 10b5-1 Plan